Tag Archives: Stuart Reynolds

Solvency II analysis of life insurers in Europe

In this report, Milliman’s Neil ChristyStuart Reynolds, and Samuel Burgess focus on the solvency and financial condition reports published in 2020 which refer to year-end 2019. The analysis of the European life insurance market covers more than 690 companies from 31 countries and one territory, representing approximately €824 billion of gross written premium and approximately €7,981 billion of gross technical provisions.

Analysis of life insurers’ Solvency and Financial Condition Reports Year-end 2018

This report by Milliman’s Neil Christy, Stuart Reynolds, and William Smith focusses on the Solvency and Financial Condition Reports published in 2019 which refer to year-end 2018. Our analysis of the European life insurance market covers over 650 companies from 31 countries and one territory. The charts and results focus on nine of the largest European life insurance markets by the total volume of Technical Provisions.

Analysis of life insurers’ second set of Solvency and Financial Condition Reports: European and UK life insurers

This analysis by Milliman consultants of the European life insurance market covers 600 companies from 31 countries and one territory, representing approximately £612 billion (€691 billion) of gross written premium and approximately £6,508 billion (€7,302 billion) of gross technical provisions. It is based on a sample of insurers that are primarily focussing on selling life insurance business and, as a result, some composite companies have been excluded from the analysis.

What is the extent of spreadsheet usage by insurers?

Spreadsheets are powerful, versatile and accessible to almost anyone. It is no surprise, therefore, that across all business functions actuaries and other insurance professionals consistently turn to spreadsheets to perform a wide variety of tasks of differing complexity and materiality, ranging from performing simple calculations to using spreadsheets as tools to inform key business decisions.

Milliman has surveyed nearly 200 life actuaries and insurance professionals to understand the way they use spreadsheets in their work, including looking at potential improvements that could be made to this important tool. In this article, Milliman’s Stuart Reynolds, William Smith, and Jennifer Strickland analyse the results of this survey, highlight our key findings and consider the benefits and risks arising from a reliance on spreadsheets.

Milliman analysis shows uncertain future for embedded value reporting in European insurance market

Milliman has announced the availability of a new report detailing embedded value (EV) results for 19 major insurance companies in Europe. The report examines trends among the companies reporting EVs as of year-end 2016, comparing practices adopted and discussing reporting issues following the implementation of Solvency II in Europe and the move toward the global adoption of International Financial Reporting Standards (IFRS).

“The future of embedded value reporting in Europe remains uncertain—although there has been increased alignment between EV and Solvency II reporting, we have continued to witness a gradual reduction in the number of firms reporting on an EV basis,” said Philip Simpson, a principal and consulting actuary in Milliman’s London office. “And with Solvency II disclosures via the SFCR lacking information around new business or analysis of change, for example, there is potentially a void appearing in the level of granularity of financial information reported.”

The release of the final IFRS 17 standard in May 2017 could signal an alternative reference point for Market Consistent Embedded Value (MCEV). And with substantial disclosure requirements involved, this may allow a sufficient amount of information to be obtained about the profitability of the business. However, the preparation of accounts under IFRS 17 gives rise to a different interpretation and timing of profit and loss compared with an EV basis, which will need to be considered. Ultimately time will tell whether companies use Solvency II or IFRS 17 as the reference point for MCEV.

Key insights from the European report include:

• There has been an ongoing, though moderate, reduction in firms reporting on an embedded value basis in 2016 compared with 2015.
• An amendment to the European Insurance CFO Forum Market Consistent Embedded Value Principles© (the MCEV Principles) was issued in May 2016, which permits the use of the projection methods and assumptions for market-consistent solvency regimes (e.g., Solvency II) in EV reporting. In light of this, during 2016 companies continued to change their approaches, with a continued trend to align EV and Solvency II reporting.
• The CFO Forum members (that disclosed their embedded values at the end of 2016) reported a combined embedded value of GBP 263 billion (EUR 308 billion) at the end of 2016 compared with GBP 246 billion (EUR 288 billion) at the end of 2015. Experience amongst the companies studied was mixed, with around half of companies experiencing an increase in embedded value compared with 2015.
• Overall, results for new business were fairly positive for the majority of companies in the report. The total value of new business (VNB) written by the current CFO Forum members (that disclosed their values of new business at the end of 2016) was GBP 11.3 billion (EUR 13.3 billion) in 2016, compared like-for-like with GBP 10.1 billion (EUR 11.9 billion) in 2015.

To download the report, click here.

Solvency II: Recalculation of the Transitional Measure on Technical Provisions

For many firms, year-end 2017 will be the first time that they need to recalculate the Transitional Measure on Technical Provisions (TMTP relief), although some firms have already applied and received approval for a recalculation following material changes in their risk profiles.

Milliman consultants have experience in recalculating the TMTP relief for a number of clients, performing independent reviews of recalculated TMTP relief, and have provided assistance with the development and review of firms’ recalculation policies.

This update by Milliman’s Oliver GillespieEmma Hutchinson, Marie-Lise Tassoni, and Stuart Reynolds summarises findings from these exercises, along with our own views on different potential approaches to recalculating the TMTP relief and associated key issues and challenges.